I SCIENCE & INNOVATION According to Riin Ehin, the Competence Centre for Cancer Research has developed 28 molecular genetic tests which aim to predict genetic risk for certain types of cancer and adjust treatments for cancer.
Estonia makes its way onto the world map with new cancer medication Life in Estonia visited the Competence Centre for Cancer Research to find out which of their projects may reach the world market in the near future
Text: Holger Roonemaa Photos: Atko Januson and Jaanar Nikker In a suburb of Tallinn, next to the Skype Estonia Development Centre, a group of focussed scientists are working on a drug candidate called Virexxa. If all goes well, this drug meant for treating rare forms of endometrial cancer will reach the market within the next two years. A comparison with Skype is not arbitrary, as this parallel was drawn by Indrek Kasela from the Amber Trust Foundation, one of the organizations that has invested in the development of this drug candidate. The drug candidate is being developed in collaboration with Kevelt Ltd., Tallinn University of Technology and the North Estonian Medical Centre.
20
LIFE IN ESTONIA I 2013 / 2014 WINTER